The evaluation for usefulness of dienogest to prevent decline of ovarian reserve by cystectomy for endometriomas

JRCT ID: jRCTs041180140

Registered date:29/03/2019

Basic Information

• Recruitment status: Complete
• Health condition(s) or Problem(s) studied: Health Condition(s) or Problem(s) StudiedOvarian endometrial cyst
• Date of first enrollment: 14/06/2016
• Target sample size: 60
• Study type: Interventional
• Intervention(s): Administration of dienogest or buserelin

Outcome(s)

• Primary Outcome: Comparison of serum AMH levels
• Secondary Outcome: Serum FSH levels, pregnancy rate, findings of ultrasonography

Key inclusion & exclusion criteria

• Age minimum: >= 20age old
• Age maximum: <= 42age old
• Gender: Female
• Include criteria: 20-42 years old women with semi- or bi- lateral ovarian endometrioma more than 4cm diameter.
• Exclude criteria: history of hormonal treatment, ovarian operation, malignant tumor, polycystic ovarian syndorome

Related Information

• Primary Sponsor: Osuka Satoko
• Source(s) of Monetary Support: Contact Mochida Pharmaceutical Co., Ltd.
• Secondary ID(s): UMIN-CTR000033605